Clinical Trial: Far Infrared Irradiation for Managing, Control and Treatment of Huntington's Disease (HD)

Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional

Official Title: Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for Control, Management and Treatment of HD

Brief Summary:

Huntington's disease (HD) is a fatal disease with profound neurological and behavioral features. HD is typically characterized by uncontrollable movements and psychological disturbances.

This study will investigate the use of far infrared radiation for control, management and treatment of HD.

Detailed Summary:

Observations from our research studies indicate that, far infrared rays provide energy to the body, improve the autonomic functions of the nervous system, restore the functions of the endocrine system, strengthen the immune system, improve blood circulation and increase the level of oxygen in the cells and promote the regeneration of muscle cells, nerves and brain cells.

It is hereby postulated that irradiation using far infrared, with wavelength between 5 to 20 microns, of the central nervous system, the endocrine system and the whole body could prevent, control, manage or possibly lead to complete rehabilitation of people who have HD.

Sponsor: GAAD Medical Research Institute Inc.

Current Primary Outcome: Treatment of people with HD [ Time Frame: 2 years ]

Original Primary Outcome: Same as current

Current Secondary Outcome: Rehabilitation of people with HD [ Time Frame: 2 Years ]

Original Secondary Outcome: Same as current

Information By: GAAD Medical Research Institute Inc.

Dates:
Date Received: May 6, 2008
Date Started: May 2008
Date Completion: June 2010
Last Updated: January 2, 2009
Last Verified: January 2009